Striatal neural grafting improves cortical metabolism in Huntington's disease patients

Brain

Volumn 127, Issue 1, 2004, Pages 65-72

  Gaura, Véronique ^a,b   Bachoud Lévi, Anne Catherine ^c,d   Ribeiro, Maria Joao ^b   Nguyen, Jean Paul ^c,d   Frouin, Vincent ^b   Baudic, Sophie ^d   Brugières, Pierre ^c,d   Mangin, Jean François ^b   Boissé, Marie Françoise ^c,d   Palfi, Stéphane ^a,c   Cesaro, Pierre ^c,d   Samson, Yves ^b,e   Hantraye, Philippe ^a,b   Peschanski, Marc ^c,d   Remy, Philippe ^a,b,c  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b DIF   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cortex; Foetal graft; Huntington's disease; Metabolism; Striatum

Indexed keywords

GLUCOSE;

ADULT; ALLOGRAFT; ARTICLE; BRAIN METABOLISM; BRAIN TRANSPLANTATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; FEMALE; FETAL STRIATAL ALLOGRAFT; FETUS CELL; FOLLOW UP; FUNCTIONAL ANATOMY; GLUCOSE BRAIN LEVEL; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; MALE; MOTOR DYSFUNCTION; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRIATAL NEURAL GRAFT; STRIATE CORTEX;

EID: 9144221004     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh003     Document Type: Article

References (28)

1. Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 1996; 119: 2085-95.
2. Bachoud-Lévi A-C, Bourdet C, Brugières P, Nguyen J-P, Grandmougin T, Haddad B, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 2000a; 161: 194-202.
3. Bachoud-Lévi A-C, Remy P, Nguyen J-P, Brugières P, Lefaucheur J-P, Bourdet C, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000b; 356: 1975-9.
4. Berent S, Giordani B, Lehtinen S, Markel D, Penney JB, Buchtel HA, et al. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol 1988; 23: 541-6.
5. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci 1986; 9: 118-20.
6. Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S. Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 2001; 24: 182-8.
7. Clarke DJ, Dunnett SB, Isacson O, Sirinathsinghji DJ, Bjorklund A. Striatal grafts in rats with unilateral neostriatal lesions-I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 1988; 24: 791-801.
8. Dunnett SB, Isacson O, Sirinathsinghji DJ, Clarke DJ, Bjorklund A. Striatal grafts in rats with unilateral neostriatal lesions-III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 1988; 24: 813-20.
9. Fontaine A, Azouvi P, Remy P, Bussel B, Samson Y. Functional anatomy of neuropsychological deficits after severe traumatic brain injury: a PET study. Neurology 1999; 53: 1963-8.
10. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li X-J, Hersch SM, et al. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 2000; 97: 13877-82.
11. Friston KJ. Statistical parametric mapping and other analyses of functional imaging data. In: Toga AW, Mazziotta JC, editors. Brain mapping. The methods. San Diego: Academic Press; 1996. p. 363-86.
12. Grafton ST, Mazziotta JC, Pahl JJ, St George-Hyslop P, Haines JL, Gusella J, et al. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Arch Neurol 1992; 49: 1161-7.
13. Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002; 58: 687-95.
14. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov Disord 2001; 16: 407-23.
15. Kendall AL, Rayment FD, Torres EM, Baker HF, Ridley RM, Dunnett SB. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med 1998; 4: 727-9.
16. Kremer B, Clark CM, Almqvist EW, Raymond LA, Graf P, Jacova C, et al. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology 1999; 53: 1000-11.
17. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990; 113: 1405-23.
18. Lawrence AD, Sahakian BJ, Robbins TW. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trends Cogn Sci 1998; 2: 379-88.
19. Mangin J-F, Frouin V, Bloch I, Bendriem B, Lopez-Krahe J. Fast nonsupervised 3D registration of PET and MR images of the brain. J Cereb Blood Flow Metab 1994; 14: 749-62.
20. Mazziotta JC, Phelps ME, Pahl JJ, Huang SC, Baxter LR, Riege WH, et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 1987; 316: 357-62.
21. Palfi S, Condé F, Riche D, Brouillet E, Dautry C, Mittoux V, et al. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington's disease. Nat Med 1998; 4: 963-6.
22. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995; 68: 273-85.
23. Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, et al. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov Disord 1996; 11: 143-50.
24. Shoulson I. Huntington's disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981; 31: 1333-5.
25. Sirinathsinghji DJ, Dunnett SB, Isacson O, Clarke DJ, Kendrick K, Bjorklund A. Striatal grafts in rats with unilateral neostriatal lesions-II. In vivo monitoring of GABA release in globus pallidus and substantia nigra. Neuroscience 1988; 24: 803-11.
26. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988.
27. Wictorin K. Anatomy and connectivity of intrastriatal striatal transplants. Prog Neurobiol 1992; 38: 611-39.
28. Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986; 20: 296-303.